免責聲明
本網站僅提供窩客幫資訊參考平台, 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料(以下簡稱『內容』)。無論其為公開張貼或私下傳送,若有不實或違法情事,均為『內容』提供者之責任,窩客幫概不負責也不承擔任何法律責任。
豐華生物科技股份有限公司
文章管理
PRONULIFE® GasProtect / GasProtect-M
Targeted Solutions for Upper GI Comfort and Gastric Microbiota Balance

Global Burden of Gastric Health Challenges
More than 4.4 billion people worldwide are infected with Helicobacter pylori, accounting for over half the global population. This bacterium is a major causative agent of chronic gastritis, peptic ulcers, and gastric cancer, with particularly high prevalence in Asian countries.
Infected individuals face a 6–10× higher risk of developing gastric cancer. Additionally, over 3 billion people are estimated to suffer from chronic gastritis, closely linked to upper GI dysbiosis.

Formulation Objectives of PRONULIFE® GasProtect
PRONULIFE® GasProtect is formulated to deliver daily support for upper GI health and microbial balance. By leveraging synergistic effects of selected probiotic strains, it helps maintain digestive comfort and mucosal defense.
  • Multi-strain formulation designed to regulate the gastric microbiot
  • Demonstrated inhibition of pathogenic adhesion and growth
  • Supports mucosal barrier integrity and improves daily digestive resilience

Formulation Information

ProductProbiotic Strains
PRONULIFE® GasProtectLactobacillus salivarius AP-32
Lactobacillus rhamnosus F-1
Lactobacillus plantarum LPL28
PRONULIFE® GasProtect-MLactobacillus johnsonii MH-68
Lactobacillus salivarius AP-32
Lactobacillus rhamnosus F-1
Lactobacillus acidophilus TYCA06
All strains are patent-registered and produced in our own GMP-certified facility to ensure consistent quality and long-term viability.

Key Benefits
Supports balanced gastric microbiota and mucosal barrier integrity
Helps relieve upper abdominal discomfort and postprandial unease
Protected by international patents and supported by functional research
Suitable for daily supplements or advanced formulation integration

Patents
  • TWI384990|Application of Lactobacillus strains in food/pharmaceutical compositions for promoting gastric comfort
  • ZL 201110179109.2 (CN102835666B)|Use of Lactobacillus strains in gastric-targeted formulations


📩 For technical data, customization inquiries, or formulation partnerships, contact us at
📧 glac@glac.com.tw

 

Further Reading: PRONULIFE® Functional Probiotic Ingredients🔙
相關文章
豐華生物科技股份有限公司
電話 : +886-6-589-1876 地址 : 1 F., No. 139, Sanmin St., Xinshi Dist., Tainan City 744007, Taiwan (R.O.C.) 信箱 : glac@glac.com.tw

  • 服務項目

  • 特別關鍵字